Aberdeen Group
ELV icon

Aberdeen Group’s Elevance Health ELV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$99M Sell
255,889
-22,591
-8% -$8.74M 0.17% 115
2025
Q1
$121M Sell
278,480
-69,523
-20% -$30.2M 0.24% 87
2024
Q4
$128M Sell
348,003
-12,131
-3% -$4.47M 0.24% 90
2024
Q3
$187M Buy
360,134
+87,717
+32% +$45.4M 0.34% 57
2024
Q2
$148M Sell
272,417
-7,504
-3% -$4.07M 0.28% 71
2024
Q1
$145M Buy
279,921
+1,524
+0.5% +$790K 0.28% 74
2023
Q4
$131M Buy
278,397
+129,364
+87% +$61M 0.28% 79
2023
Q3
$64.9M Buy
149,033
+1,393
+0.9% +$607K 0.17% 125
2023
Q2
$65.6M Buy
147,640
+11,488
+8% +$5.1M 0.15% 133
2023
Q1
$62.6M Buy
136,152
+7,687
+6% +$3.53M 0.16% 135
2022
Q4
$65.9M Buy
128,465
+31,769
+33% +$16.3M 0.18% 124
2022
Q3
$43.9M Buy
96,696
+23,736
+33% +$10.8M 0.13% 168
2022
Q2
$35.3M Sell
72,960
-85
-0.1% -$41.1K 0.11% 199
2022
Q1
$36.9M Sell
73,045
-32,225
-31% -$16.3M 0.09% 222
2021
Q4
$48.8M Sell
105,270
-6,112
-5% -$2.83M 0.11% 195
2021
Q3
$42.4M Sell
111,382
-3,902
-3% -$1.48M 0.1% 218
2021
Q2
$44M Sell
115,284
-7,025
-6% -$2.68M 0.1% 202
2021
Q1
$43.9M Buy
122,309
+12,656
+12% +$4.54M 0.1% 202
2020
Q4
$35.2M Buy
109,653
+2,421
+2% +$777K 0.09% 212
2020
Q3
$28.8M Sell
107,232
-12,724
-11% -$3.42M 0.08% 204
2020
Q2
$31.5M Sell
119,956
-3,359
-3% -$883K 0.09% 211
2020
Q1
$28M Buy
123,315
+2,308
+2% +$524K 0.09% 193
2019
Q4
$36.5M Sell
121,007
-112,449
-48% -$34M 0.09% 194
2019
Q3
$56.1M Sell
233,456
-37,779
-14% -$9.07M 0.14% 130
2019
Q2
$76.5M Sell
271,235
-12,088
-4% -$3.41M 0.17% 111
2019
Q1
$81.3M Sell
283,323
-343,711
-55% -$98.7M 0.18% 112
2018
Q4
$164M Sell
627,034
-81,252
-11% -$21.2M 0.39% 72
2018
Q3
$194M Sell
708,286
-80,895
-10% -$22.2M 0.36% 75
2018
Q2
$188M Sell
789,181
-35,907
-4% -$8.55M 0.36% 70
2018
Q1
$181M Buy
825,088
+518,258
+169% +$114M 0.36% 76
2017
Q4
$69.1M Sell
306,830
-5,159
-2% -$1.16M 0.13% 150
2017
Q3
$59.2M Buy
+311,989
New +$59.2M 0.11% 183